BUY Aster DM Healthcare Limited — Anshul Jain, Lakshmishree Investment and Securities
byAnshul Jain, Lakshmishree Investment and SecuritiesHorizon: NA (inferred 1–3 months)13 May 2026via Business Today
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Broker’s Call: Aster DM Healthcare (Buy)
NewsHbl·8 Aug · 5d ago
Aster DM Quality Care Limited has acquired equity shares of United CIIGMA Institute of Medical Sciences, a subsidiary.
NSE · Acquisition·5 Aug · 1w ago
Aster DM Quality Care Limited announced strong Q1 FY27 financial results with revenue up 20% to INR 2,597 Cr and operating EBITDA up 30% to INR 576 Cr. The company also highlighted the merger becoming
NSE · Press Release·5 Aug · 1w ago
1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·6 Aug · 1w ago
CRISIL has assigned credit ratings to Aster DM Quality Care Ltd's bank facilities: AA+/Stable for long-term (860.50 crore) and A1+ for short-term (assigned). These ratings were novated following the c
BSE · Company Update·30 Jul · 2w ago
Broker’s Call: Aster DM Healthcare (Buy)
NewsHbl·7 Aug · 5d ago
Aster DM Quality Care Limited announced its unaudited financial results for the quarter ended June 30, 2026. The results were reviewed by the Audit Committee and approved by the Board of Directors.
NSE · Outcome of Board Meeting·5 Aug · 1w ago
Aster DM Healthcare to rename as Aster DM Quality Care Limited
NewsGoogle News·25 Jul · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.